Histamine H1 receptors on adherent rheumatoid synovial cells in culture: demonstration by radioligand binding and inhibition of histamine-stimulated prostaglandin E production by histamine H1 antagonists.
Histamine H1 receptors have been demonstrated on adherent rheumatoid synovial cells using biochemical and radioligand binding assays in vitro. The addition of histamine (17.8 mumol/l) to nine primary cultures of adherent rheumatoid synovial cells resulted in a two- to 21-fold increase in the production of prostaglandin E (PGE). This increase was inhibited by three H1 receptor antagonists (mepyramine, tripelennamine, and chlorpheniramine) in a dose related manner at concentrations below 10(-6) mol/l. Competitive binding assays with [3H]mepyramine gave ED50 values of approximately 10(-5) mol/l for the three H1 antagonists. H2 receptor antagonists (cimetidine and ranitidine) did not inhibit the histamine induced increase in PGE and did not compete effectively with the binding of H1 antagonists.
D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D001667:Binding, Competitive; D002478:Cells, Cultured; D002744:Chlorpheniramine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D011458:Prostaglandins E / Q000096:biosynthesis*; D011738:Pyrilamine / Q000494:pharmacology; D011869:Radioligand Assay; D011969:Receptors, Histamine H1 / Q000032:analysis; D013583:Synovial Membrane / Q000187:drug effects / Q000378:metabolism*; D014309:Tripelennamine / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D011458:Prostaglandins E; D011969:Receptors, Histamine H1; D014309:Tripelennamine; D002744:Chlorpheniramine; D006632:Histamine; D011738:Pyrilamine